Condition

Cerebral Small Vessel Diseases

ClinicalTrials.gov condition label

Clinical trials7

Recruiting1

Common interventions16

Lead sponsors shown6

Clinical trials

7 shown

MRI-Based Lesion Differentiation in Older Patients With Multiple SclerosisNCT07444047 · 2026-05-11

Songling Xuemaikang Capsules for Cerebral Small Vessel DiseaseNCT07271732 · 2025-12-10

NOT_YET_RECRUITING

Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVDNCT05169021 · 2021-12-31

NOT_YET_RECRUITING

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-StudyNCT03785067 · 2020-02-27

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-studyNCT03783754 · 2018-08-09

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular FunctionNCT03082014 · 2018-02-22

LACunar Intervention (LACI-2) Trial-2NCT03451591 · 2018-01-08

Common interventions

Placebo oral capsuleDRUG2 AmlodipineDRUG1 Amlodipine folic acid 5.8mg+intensive antihypertensive therapyDRUG1 Amlodipine folic acid 5.8mg+standard antihypertensive therapyDRUG1 Amlodipine+intensive antihypertensive therapyDRUG1 Amlodipine+standard antihypertensive therapyDRUG1 AtenololDRUG1 CilostazolDRUG1 ISMN XL and CilostazolDRUG1 Isosorbide Mononitrate XL (ISMN)DRUG1 LosartanDRUG1 Neither ISMN nor cilostazolOTHER1 Songling Xuemaikang CapsuleDRUG1 Songling Xuemaikang Capsule PlaceboDRUG1 telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mgDRUG1 telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mgDRUG1

Leading sponsors

The George Institute2 Beijing Tiantan Hospital1 Dongzhimen Hospital, Beijing1 Ludwig-Maximilians - University of Munich1 Oslo University Hospital1 University of Edinburgh1

Trial status mix

TERMINATED3

NOT_YET_RECRUITING2

COMPLETED1

RECRUITING1

Phase mix

PHASE33

NA2

PHASE21

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.